All patients receiving treatment for their haemophilia with clotting factors or currently marketed bispecific antibodies mimicking the function of clotting factor VIII. florio HAEMO now also supports patients with allied disorders , including factor I, II, V, VII, IX, X, XI and XIII deficiencies, Von Willebrand disease and Glanzmann thrombasthenia, and is open to factor and non-factor replacement products, including bypassing agents.